Literature DB >> 1748279

Coactivators for a proline-rich activator purified from the multisubunit human TFIID complex.

N Tanese1, B F Pugh, R Tjian.   

Abstract

The mechanisms of transcriptional activation directed by sequence-specific regulators is central to understanding gene regulation. Here, we report the isolation of coactivators responsible for mediating transcriptional activation by Gal4-Pro, a hybrid regulator containing the proline-rich activation domain of human CTF/NFI. Chromatographic studies indicate that endogenous human TFIID consists of a multisubunit complex containing the TATA-binding protein (TBP), coactivators, and other associated factors. A fraction containing the coactivator activity was separated from the endogenous TBP after disrupting the tightly associated complex with urea. The urea-purified TBP was active for basal level transcription but no longer could support activation by Gal4-Pro. However, when the two separated components were added together, activated levels of transcription were restored in the presence of Gal4-Pro. Immunoaffinity purification of the TFIID complex identifies several polypeptides specifically associated with the endogenous TBP, some or all of which function as coactivators when reconstituted with Gal4-Pro. The isolated coactivators also mediate activation by a chimeric glutamine-rich activator derived from Sp1 but not the Gal4-VP16 activator, suggesting distinct factor requirements for different types of transcriptional regulators.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1748279     DOI: 10.1101/gad.5.12a.2212

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  135 in total

1.  Requirement for TAF(II)250 acetyltransferase activity in cell cycle progression.

Authors:  E L Dunphy; T Johnson; S S Auerbach; E H Wang
Journal:  Mol Cell Biol       Date:  2000-02       Impact factor: 4.272

2.  Downregulation of constitutive and heavy metal-induced metallothionein-I expression by nuclear factor I.

Authors:  S Majumder; K Ghoshal; R M Gronostajski; S T Jacob
Journal:  Gene Expr       Date:  2001

3.  Nuclear relocalization of the pre-mRNA splicing factor PSF during apoptosis involves hyperphosphorylation, masking of antigenic epitopes, and changes in protein interactions.

Authors:  Y Shav-Tal; M Cohen; S Lapter; B Dye; J G Patton; J Vandekerckhove; D Zipori
Journal:  Mol Biol Cell       Date:  2001-08       Impact factor: 4.138

4.  Developmental regulation of transcription by a tissue-specific TAF homolog.

Authors:  M A Hiller; T Y Lin; C Wood; M T Fuller
Journal:  Genes Dev       Date:  2001-04-15       Impact factor: 11.361

5.  The Epstein-Barr virus R transactivator (Rta) contains a complex, potent activation domain with properties different from those of VP16.

Authors:  J M Hardwick; L Tse; N Applegren; J Nicholas; M A Veliuona
Journal:  J Virol       Date:  1992-09       Impact factor: 5.103

6.  Molecular cloning and characterization of additional factors that bind to the interferon-alpha/beta response element B of the murine (2'-5')oligoadenylate synthetase ME-12 gene.

Authors:  C Yan; I Tamm
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-01       Impact factor: 11.205

7.  A novel, erythroid cell-specific murine transcription factor that binds to the CACCC element and is related to the Krüppel family of nuclear proteins.

Authors:  I J Miller; J J Bieker
Journal:  Mol Cell Biol       Date:  1993-05       Impact factor: 4.272

8.  TAFII105 mediates activation of anti-apoptotic genes by NF-kappaB.

Authors:  A Yamit-Hezi; R Dikstein
Journal:  EMBO J       Date:  1998-09-01       Impact factor: 11.598

9.  A cell-specific factor represses stimulation of transcription in vitro by transcriptional enhancer factor 1.

Authors:  S Chaudhary; C Brou; M E Valentin; N Burton; L Tora; P Chambon; I Davidson
Journal:  Mol Cell Biol       Date:  1994-08       Impact factor: 4.272

10.  Proline-rich activator CTF1 targets the TFIIB assembly step during transcriptional activation.

Authors:  T K Kim; R G Roeder
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.